The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
Third Quarter 2023 Results (for the three months ended September 30, 2023)
- Third Quarter 2023 Results (for the three months ended September 30, 2023)
Consolidated revenue for Q3 2023 was $82.0 million, an increase of 26.3% compared to Q3 2022, and a 2.3% increase compared to Q2 2023. - Revenue for patient services the nine months ended 2023 was $157.3 million, up 32.4% compared to the nine months ended 2022.
- Gross profit in the nine months ended 2023 was $45.2 million, an increase of 23.9% compared to the nine months ended 2022.
- TOI will host a conference call and webcast on Wednesday, November 8, 2023 at 5:00 p.m. (Eastern Time) to discuss third quarter results.